Showing 1 - 10 of 3,998
Persistent link: https://www.econbiz.de/10012013562
this paper, we take a close look at competition among the generic entrants during the first three years after patent …Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In … expiration and examine whether there is a first mover advantage. We specify a random effect nested logit model of competition …
Persistent link: https://www.econbiz.de/10012709667
to "reach for mediocrity" by investing in socially suboptimal projects, even in the presence of competition and new … underinvestment problem. In particular, we describe a new approach for a "value-based" patent system, which ties patent protection to …
Persistent link: https://www.econbiz.de/10013251136
-cycle of new drugs are regulated, from patent application, to marketing approval, commercial exploitation, patent expiration … and competition with generics. The nature of demand for drugs, the identity of drugs brought to market, and the nature of … competition in the drug market over time are all shaped by regulation. Throughout much of the world, administrative regulation …
Persistent link: https://www.econbiz.de/10012980141
This paper looks into various means of regulating pharmaceuticals and their effects on the structure of the … industry and thereby a factor for industry concentration. High industry concentration leads to reduced competition which in … industry activities proceeds, national regulation aimed at reducing costs for pharmaceuticals can have the unintended effect of …
Persistent link: https://www.econbiz.de/10013127115
Persistent link: https://www.econbiz.de/10012294915
We study how competition impacts innovation (and welfare) when firms compete both in the product market and in … innovation development. This relationship is complex and may lead to scenarios in which a lessening of competition increases R … provide conditions for when competition increases or decreases industry innovation and welfare. These conditions are based on …
Persistent link: https://www.econbiz.de/10012929200
R&D and market competition. Most of the literature on patent disclosure has highlighted the trade-offs involved by the … and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed …, Mansfield (1986) found that, absent patent protection, 60 percent of pharmaceutical inventions would not have been developed and …
Persistent link: https://www.econbiz.de/10014216850
model to study consumers’ buying behavior and firm competition in the post patent ethical drug markets. We use the estimated … study the post patent ethical drug market and simulate the impact of ACA on individuals, healthcare providers and … paper is the first to illustrate the potential policy effect of Obamacare through a structural model on post patent ethical …
Persistent link: https://www.econbiz.de/10014036939
Persistent link: https://www.econbiz.de/10014434790